We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDYG icon
1101
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.83B
$154K ﹤0.01%
2,725
– –
CMPR icon
1102
Cimpress
CMPR
$2.43B
$153K ﹤0.01%
1,223
– –
HCSG icon
1103
Healthcare Services Group
HCSG
$1.63B
$153K ﹤0.01%
6,300
– –
FNV icon
1104
Franco-Nevada
FNV
$40.6B
$152K ﹤0.01%
1,473
-68
-4% -$6.57K
INFY icon
1105
Infosys
INFY
$50B
$152K ﹤0.01%
14,732
-844
-5% -$8.49K
MTN icon
1106
Vail Resorts
MTN
$5.6B
$152K ﹤0.01%
634
+15
+2% +$3.55K
DRNA
1107
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$151K ﹤0.01%
+6,855
New +$138K
C.PRJ
1108
DELISTED
CITIGROUP INC. Depositary Shares, Each Representing a 1/1,000th Interest in a Share of 7.125% Fixed Rate / Floating Rate Noncumulative Preferred Stock, Series J
C.PRJ
$151K ﹤0.01%
5,332
– –
AAN.A
1109
DELISTED
The Aaron's Company Inc Class A
AAN.A
$150K ﹤0.01%
2,640
-345,149
-99% -$19.6M
RCI icon
1110
Rogers Communications
RCI
$18.8B
$149K ﹤0.01%
3,019
-317
-10% -$15.3K
SSTK icon
1111
Shutterstock
SSTK
$220M
$149K ﹤0.01%
3,497
+66
+2% +$2.65K
KTB icon
1112
Kontoor Brands
KTB
$4.87B
$147K ﹤0.01%
3,524
+198
+6% +$7.48K
RACE icon
1113
Ferrari
RACE
$68.6B
$147K ﹤0.01%
892
+6
+0.7% +$971
LSXMA
1114
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$147K ﹤0.01%
4,222
– –
HLI icon
1115
Houlihan Lokey
HLI
$10.2B
$145K ﹤0.01%
+2,982
New +$141K
OBOR icon
1116
Kraneshares MSCI One Belt One Road Index ETF
OBOR
$3.91M
$145K ﹤0.01%
6,000
– –
ZION icon
1117
Zions Bancorporation
ZION
$10.1B
$145K ﹤0.01%
2,814
-14
-0.5% -$680
NTRA icon
1118
Natera
NTRA
$36.1B
$144K ﹤0.01%
4,279
+194
+5% +$7.15K
CBZ icon
1119
CBIZ
CBZ
$2.51B
$143K ﹤0.01%
5,330
+2,376
+80% +$61.8K
EPAY
1120
DELISTED
Bottomline Technologies Inc
EPAY
$143K ﹤0.01%
2,675
+742
+38% +$33.8K
LOPE icon
1121
Grand Canyon Education
LOPE
$3.99B
$142K ﹤0.01%
1,484
+302
+26% +$27.9K
GGAL icon
1122
Galicia Financial Group
GGAL
$7.9B
$141K ﹤0.01%
8,715
– –
XMMO icon
1123
Invesco S&P MidCap Momentum ETF
XMMO
$7.15B
$140K ﹤0.01%
2,302
– –
DELL icon
1124
Dell
DELL
$253B
$139K ﹤0.01%
5,394
-359
-6% -$9.34K
IYR icon
1125
iShares US Real Estate ETF
IYR
$4.76B
$139K ﹤0.01%
1,504
-155
-9% -$14.4K
43 44
45
46 47

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.